Indian Government Appoints Panel To Restrict Import Of Refurbished Radiology Devices
This article was originally published in SRA
The Indian government has issued orders to appoint an inter-ministerial committee to restrict the import of refurbished radiology devices and to examine whether to stop such imports, the approval requirements that are in place for such products, concerns around patient safety and the barriers faced by the domestic industry1.
You may also be interested in...
India will finally get a device-specific regulatory framework when new rules formed by the government come into force next year. While the medtech industry has welcomed this long-awaited development, it hopes that its outstanding concerns will be addressed before the rules come into play.
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.